Tag: Subarachnoid hemorrhage

For up to 90% of patients with aneurysmal subarachnoid hemorrhage (aSAH), severe headache is a major and often persistent symptom during hospitalization. Given the complex and delicate nature of a brain bleed, selecting the appropriate **medication used for brain bleed headaches** requires careful consideration to manage pain effectively without causing further complications. This article provides a comprehensive overview of pharmacological strategies used in neurocritical care for treating headaches associated with intracranial hemorrhage.

According to research, nimodipine, known by the brand name Nimotop, is the only established pharmacological treatment proven to improve outcomes for patients suffering from subarachnoid hemorrhage (SAH). This medication achieves its effect by interfering with specific cellular processes in the brain to reduce secondary injury.